CN108210691A - 一种治疗骨折伤的膏药及其制备方法 - Google Patents
一种治疗骨折伤的膏药及其制备方法 Download PDFInfo
- Publication number
- CN108210691A CN108210691A CN201810188609.4A CN201810188609A CN108210691A CN 108210691 A CN108210691 A CN 108210691A CN 201810188609 A CN201810188609 A CN 201810188609A CN 108210691 A CN108210691 A CN 108210691A
- Authority
- CN
- China
- Prior art keywords
- parts
- plaster
- chinese medicine
- blood
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011505 plaster Substances 0.000 title claims abstract description 72
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 60
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 claims abstract description 58
- 239000003937 drug carrier Substances 0.000 claims abstract description 39
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 32
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 32
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 32
- 241001148782 Davallia Species 0.000 claims abstract description 32
- 239000004863 Frankincense Substances 0.000 claims abstract description 32
- 244000153234 Hibiscus abelmoschus Species 0.000 claims abstract description 30
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 29
- 241000545744 Hirudinea Species 0.000 claims abstract description 29
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 29
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 29
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 29
- 229940075397 calomel Drugs 0.000 claims abstract description 29
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 28
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 28
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 28
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 28
- 241000195947 Lycopodium Species 0.000 claims abstract description 28
- 229910052802 copper Inorganic materials 0.000 claims abstract description 28
- 239000010949 copper Substances 0.000 claims abstract description 28
- 244000226566 Psoralea corylifolia Species 0.000 claims abstract description 27
- 239000008159 sesame oil Substances 0.000 claims abstract description 27
- 235000011803 sesame oil Nutrition 0.000 claims abstract description 27
- 241000123589 Dipsacus Species 0.000 claims abstract description 26
- 241000208688 Eucommia Species 0.000 claims abstract description 26
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 26
- 239000009136 dragon's blood Substances 0.000 claims abstract description 26
- 239000002994 raw material Substances 0.000 claims abstract description 19
- 208000010392 Bone Fractures Diseases 0.000 claims description 49
- 206010017076 Fracture Diseases 0.000 claims description 48
- 208000027418 Wounds and injury Diseases 0.000 claims description 46
- 239000000843 powder Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 11
- 239000003053 toxin Substances 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 6
- 235000019504 cigarettes Nutrition 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 5
- 235000019198 oils Nutrition 0.000 claims description 5
- 231100000614 poison Toxicity 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 239000008188 pellet Substances 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 3
- 235000008216 herbs Nutrition 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 230000035800 maturation Effects 0.000 claims description 3
- 239000000155 melt Substances 0.000 claims description 3
- 239000002574 poison Substances 0.000 claims description 3
- 238000013019 agitation Methods 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 32
- 239000008280 blood Substances 0.000 abstract description 31
- 208000002193 Pain Diseases 0.000 abstract description 24
- 230000036407 pain Effects 0.000 abstract description 23
- 210000000988 bone and bone Anatomy 0.000 abstract description 19
- 230000001737 promoting effect Effects 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 17
- 230000017531 blood circulation Effects 0.000 abstract description 11
- 210000002435 tendon Anatomy 0.000 abstract description 9
- 238000005469 granulation Methods 0.000 abstract description 6
- 230000003179 granulation Effects 0.000 abstract description 6
- 230000035876 healing Effects 0.000 abstract description 6
- 230000004087 circulation Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 206010052428 Wound Diseases 0.000 description 31
- 208000014674 injury Diseases 0.000 description 20
- 210000004185 liver Anatomy 0.000 description 18
- 210000003734 kidney Anatomy 0.000 description 16
- 230000008736 traumatic injury Effects 0.000 description 13
- 210000003205 muscle Anatomy 0.000 description 11
- 238000011084 recovery Methods 0.000 description 11
- 206010042674 Swelling Diseases 0.000 description 9
- 230000006378 damage Effects 0.000 description 9
- 230000008961 swelling Effects 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 6
- 230000036592 analgesia Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000003169 central nervous system Anatomy 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- -1 scattered Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000024779 Comminuted Fractures Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- AMZNYVFIWCPUAY-UHFFFAOYSA-N clavatol Chemical compound CC(=O)C1=CC(C)=C(O)C(C)=C1O AMZNYVFIWCPUAY-UHFFFAOYSA-N 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 229910052602 gypsum Inorganic materials 0.000 description 2
- 239000010440 gypsum Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000002303 tibia Anatomy 0.000 description 2
- AGTWEFWCYVDEIC-UHFFFAOYSA-N (1R,1'R,2S,2'S,4aR,4R,6R,6'S,8aS,8S)-1,1'-(ethane-1,2-diyl)bis[decahydro-5,5,8a-trimethylnaphthalene-2,6-diol] Natural products OC1CCC2C(C)(C)C(O)CCC2(C)C1CCC1C2(C)CCC(O)C(C)(C)C2CCC1O AGTWEFWCYVDEIC-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000007625 Hirudins Human genes 0.000 description 1
- 108010007267 Hirudins Proteins 0.000 description 1
- 241000237903 Hirudo Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023204 Joint dislocation Diseases 0.000 description 1
- 206010061599 Lower limb fracture Diseases 0.000 description 1
- 241001124569 Lycaenidae Species 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 206010064251 Onychalgia Diseases 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000005214 Poroma Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000003167 anti-vitamin Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000014987 copper Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000001013 eccrine acrospiroma Diseases 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000002082 fibula Anatomy 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 210000001255 hallux Anatomy 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 210000005096 hematological system Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
- 229940006607 hirudin Drugs 0.000 description 1
- 210000002758 humerus Anatomy 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001965 increasing effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000000236 metacarpal bone Anatomy 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 239000012783 reinforcing fiber Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000323 shoulder joint Anatomy 0.000 description 1
- NCTHNHPAQAVBEB-WGCWOXMQSA-M sodium ferulate Chemical compound [Na+].COC1=CC(\C=C\C([O-])=O)=CC=C1O NCTHNHPAQAVBEB-WGCWOXMQSA-M 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Insects & Arthropods (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药技术领域,具体公开了一种治疗骨折伤的膏药及其制备方法,所述膏药的制备原料包括中药材和药学上可接受的载体,所述中药材包括:三七40‑50份、续断20‑30份、补骨脂20‑30份、土鳖虫5‑15份、五加皮10‑20份、生杜仲10‑20份、红花5‑15份、骨碎补20‑30份、当归10‑30份、川芎10‑20份、乳香20‑30份、没药20‑30份、水蛭5‑10份、伸筋草15‑30份、自然铜15‑30份、轻粉5‑10份、血竭10‑30份、麝香2‑4份;所述药学上可接受的载体包括:麻油2000‑3000份、黄丹1000‑1200份;本发明所制得的膏药具有活血化瘀、行气止痛、消肿生肌、续筋接骨之功效,对骨折伤疗效显著,见效快,治愈时间短,安全可靠,无毒副作用,且成本低廉,使用方便,制作方法简单。
Description
技术领域
本发明涉及中药技术领域,具体涉及一种治疗骨折伤的膏药及其制备方法。
背景技术
膏药,是中药五大剂型—丸、散、膏、丹、汤之一,是祖国传统医学宝库的重要组成部分。清代著名外治法医家吴尚先有言:“膏药治病,无殊汤药,用之得法,其响立应。”膏药外治与服汤药内治的道理是一样的,只要熟练掌握人体解剖及经络系统,仔细辨清症候,对症下药,外敷膏药就能取得与汤药同样的功效,有时还能避免汤药产生的副作用。
骨折伤目前主流的治疗方法有两种,一种是保守手法复位固定,其代表性的是复位后石膏外固定,其缺点主要有以下三点:1、创伤后的进行性肿胀,容易引起压迫而致血运障碍,甚至肢体坏死;2、肢体肿胀消退后,又因石膏过松而致骨折再移位;3、长期固定可以引起关节僵硬,肌肉萎缩,甚至严重的功能障碍。另一种是手术切开复位内固定,其缺点主要有以下四点:1、手术本身对骨折处肌肉、筋膜、血管、骨膜会造成再次创伤,甚至会造成周围神经损伤、感染等严重并发症,同时周围血管的损伤,营养供应不足可能会造成断端愈合延迟。2、操作复杂,对术者及器材设备要求很高;3、患者可能还会面临再次手术取钉的创伤痛苦;4、花费大。
使用膏药治疗骨折伤是一种有效且副作用小的治疗方法,但是现有技术中治疗骨折伤的膏药的药效仍然欠佳,需要进一步提高。
发明内容
本发明的目的在于提供一种治疗骨折伤的膏药及其制备方法,所制得的膏药具有活血化瘀、行气止痛、消肿生肌、续筋接骨之功效,对骨折伤疗效显著,见效快,治愈时间短,安全可靠,无毒副作用,且成本低廉,使用方便,制作方法简单。
为实现以上目的,本发明通过以下技术方案予以实现:
一种治疗骨折伤的膏药,其制备原料包括中药材和药学上可接受的载体,以重量份计,所述中药材包括:三七40-50份、续断20-30份、补骨脂20-30份、土鳖虫5-15份、五加皮10-20份、生杜仲10-20份、红花5-15份、骨碎补20-30份、当归10-30份、川芎10-20份、乳香20-30份、没药20-30份、水蛭5-10份、伸筋草15-30份、自然铜15-30份、轻粉5-10份、血竭10-30份、麝香2-4份;所述药学上可接受的载体包括:麻油2000-3000份、黄丹1000-1200份。
优选地,所述中药材包括:三七45份、续断25份、补骨脂25、土鳖虫10份、五加皮15份、生杜仲15份、红花10份、骨碎补25份、当归20份、川芎15份、乳香25份、没药25份、水蛭8份、伸筋草25份、自然铜25份、轻粉8份、血竭20份、麝香3份;所述药学上可接受的载体包括:麻油2500份、黄丹1100份。
优选地,所述中药材包括:三七48份、续断22份、补骨脂26份、土鳖虫15份、五加皮13份、生杜仲18份、红花12份、骨碎补28份、当归30份、川芎12份、乳香25份、没药25份、水蛭10份、伸筋草18份、自然铜22份、轻粉5份、血竭28份、麝香3.5份;所述药学上可接受的载体包括:麻油2600份、黄丹1050份。
优选地,所述中药材包括:三七40份、续断26份、补骨脂20份、土鳖虫11份、五加皮17份、生杜仲12份、红花7份、骨碎补23份、当归18份、川芎18份、乳香28份、没药22份、水蛭8份、伸筋草23份、自然铜18份、轻粉8份、血竭15份、麝香3份;所述药学上可接受的载体包括:麻油2200份、黄丹1100份。
优选地,所述中药材包括:三七45份、续断20份、补骨脂20份、土鳖虫7份、五加皮10份、生杜仲20份、红花10份、骨碎补27份、当归15份、川芎15份、乳香21份、没药21份、水蛭9份、伸筋草16份、自然铜25份、轻粉8份、血竭12份、麝香4份;所述药学上可接受的载体包括:麻油2500份、黄丹1200份。
本发明制备上述治疗骨折伤的膏药的方法,包括以下具体步骤:
步骤一:原料准备
按原料配比称取中药材及药学上可接受的载体,所述中药材包括:三七、续断、补骨脂、土鳖虫、五加皮、生杜仲、红花、骨碎补、当归、川芎、乳香、没药、水蛭、伸筋草、自然铜、轻粉、血竭、麝香;所述药学上可接受的载体包括:麻油、黄丹;
步骤二:打粉
将称取的18味中药材用中药打粉机分别打成细粉,备用;
步骤三:熬药
选用砂锅,放入麻油烧热,投入备用的三七、续断、补骨脂、土鳖虫、五加皮、生杜仲、红花、骨碎补、当归、川芎、水蛭、伸筋草、自然铜细粉,武火烧开后改小火煎熬,煎熬过程中慢慢搅动,使药材均匀融合;
步骤四:加黄丹
油珠不散时下丹,下丹时火力要适当加旺,慢慢加入黄丹,并不断搅动;黄丹下完后,以旺火熬5-10分钟,转为小火,继续熬至药液成黑色;青烟将尽,白烟上冲,药香味散出,滴水成珠时,膏药成熟出锅;
步骤五:去火毒
出锅时向水中慢慢倒入膏药,并不断搅动膏药,待冷却后,换冷水浸泡24小时,以去火毒;
步骤六:制成
将去火毒后的膏药拧干水分,放入砂锅内小火化开,将备用的乳香、没药、轻粉、血竭、麝香细粉,边搅边慢慢加入膏药中,即得所述治疗骨折伤的膏药;
步骤七:保存
将经步骤六制成的治疗骨折伤的膏药取适量摊于备好的膏药布上,制成膏药贴。
本发明中,各种中药材的药性、功效、应用以及药理简要介绍如下:
三七:甘、微苦,温。归肝、胃经。化瘀止血,活血定痛。主要用于各种出血证、跌打损伤及瘀血肿痛。本品能够缩短出血和凝血时间,具有抗血小板聚集及溶栓作用;能够促进多功能造血干细胞的增值,具有造血作用;能够提高体液免疫功能,具有镇痛、抗炎等作用。
续断:苦,辛,微温。归肝、肾经。补益肝肾,强筋健骨,止血安胎,疗伤续断。主要用于跌打损伤、筋伤骨折,腰膝酸痛、寒湿痹痛,胎动不安等。本品有抗维生素E缺乏症的作用。对疮疡有排脓、止血、镇痛、促进组织再生作用。
补骨脂:苦,辛,温。归肾、脾经。补肾壮阳,固筋缩尿,温脾止泻,纳气平喘。入肾治骨,以治肾虚阳痿,腰膝冷痛为宜。本品通过调节神经和血液系统,促进骨髓造血,增强免疫和内分泌功能。
土鳖虫:咸,寒,有小毒,归肝经。性善走窜,破血逐瘀,续筋接骨。多用于跌打损伤,筋伤骨折、瘀血肿痛。常配伍自然铜、骨碎补、乳香等同用,如接骨紫金丹(《杂病源流犀浊》);骨折筋伤后期,筋骨软弱,常配续断、杜仲等药用,如壮筋续骨丸(《伤科大成》)。本品提取物有抗血栓形成和溶解血栓的作用,有抑制血小板聚集的作用,具有调脂,延缓动脉硬化的作用。
五加皮:辛,苦,温。归肝、肾经。祛风湿,补肝肾,强筋骨,利水。主治风湿痹证,筋骨萎软等病症,本品具有抗炎、镇痛、镇静作用,能提高血清抗体的浓度、促进单核吞噬细胞的吞噬作用,有抗应激作用。
生杜仲:甘,温。归肝、肾经。补肝肾、强筋骨,以肾虚腰痛尤宜,常与补骨脂、当归、川芎等同用,治肾虚腰痛及筋骨软弱。本品提取物具有调节细胞免疫平衡的功能。
红花:辛,温。归心、肝经。活血通经、祛瘀止痛。本品善能通利血脉,消肿止痛,为治跌打损伤,瘀滞肿痛之要药。红花黄色素能扩张周围血管,能抑制血小板聚集,增强纤维蛋白溶解,降低全血粘度;对中枢神经系统有镇痛、镇静和抗惊厥作用。此外,红花醇提物和水提物有抗炎作用。
骨碎补:苦,温,归肝、肾经。活血散瘀、消肿止痛、续筋接骨。本品以其入肾治骨,能治骨伤碎而得名,为伤科要药。主要用于治跌打损伤,肾虚腰腿酸软。骨碎补多糖和骨碎补双氢黄酮苷有将血脂和抗动脉硬化的作用,骨碎补能促进骨对铁离子的吸收,提高血钙和血磷的水平,有利于骨折的愈合,改善软骨细胞,推迟骨细胞的退行性病变。
当归:甘,辛,温。归肝、心、脾经。补血调经,活血止痛,润肠通便。主要用于血虚诸证,血虚血瘀,月经不调,痛经,跌打损伤,痈疽疮疡及风寒痹痛等。当归浸膏有显著扩张离体大鼠冠脉作用,增加冠脉血流量。当归及其阿魏酸钠有明显的抗血栓作用。给小鼠口服当归水浸液,能显著促进血红蛋白及红细胞的生成。
川芎:辛,温。归肝、胆、心包经。活血行气,祛风止痛。主要用于血瘀气滞痛证,头痛,风湿痹痛。为“血中之气药”,治跌打损伤,瘀肿疼痛,可配乳香、没药、三七等同用。本品能扩张冠状动脉及脑血管,抑制血小板聚集,预防血栓形成;可加速骨折局部血肿的吸收,促进骨痂形成。
乳香:辛,苦,温。归心、肝、脾经。活血行气止痛,消肿生肌。主要用于跌打损伤,疮疡痈肿,气滞血瘀痛证,为外伤科要药。本品有镇痛、消炎、升高白细胞的作用,并能加速炎症渗出排泄,促进伤口愈合。
没药:辛,苦,温。归心、肝、脾经。活血止痛,消肿生肌。功效主治与乳香相似。常与乳香相须为用,治疗跌打损伤、瘀滞肿痛,痈疽肿痛,疮疡溃后久不收口以及一切瘀滞痛证。本品含油脂部分具有降脂、防止动脉内膜粥样斑块形成的作用;对多种真菌有抑制作用,挥发油能轻度抑制霉菌;有局部刺激作用。
水蛭:咸,苦,平。有小毒。归肝经。破血通经,逐瘀消癥。应用于血瘀经闭,癥瘕积聚,跌打损伤,心腹疼痛。水蛭水煎剂有较强抗凝血作用,能显著延长纤维蛋白的凝聚作用,水蛭提取物,水蛭素对血小板聚集有明显的抑制作用,抑制大鼠体内血栓形成,对弥漫性血管内凝血有很好的治疗作用。
伸筋草:微苦,辛,温。归肝、脾、肾经。祛风湿,舒筋活络。主治风寒湿痹,肢软麻木及跌打损伤。伸筋草醇提取物有明显镇痛作用;水浸液有解热作用。
自然铜:辛,平。归肝经。散瘀止痛,接骨疗伤。尤长于促进骨折的愈合,为伤科要药。本品能促进骨折愈合,表现为骨痂生长快,量多且较成熟;对多种病原性真菌有不同程度的拮抗作用。
轻粉:辛,寒。有毒。归大肠、小肠经。外用攻毒杀虫,敛疮。外用治疮疡溃烂,疥癣瘙痒,湿疹,梅毒下疳等。轻粉有广谱抑菌作用,对多种革兰阳性与阴性菌及致病性真菌均有良好抑菌作用。
血竭:甘、咸,平。归肝经。活血定痛,化瘀止血,敛疮生肌。主要用于跌打损伤,瘀滞心腹疼痛,外伤出血及疮疡不敛。本品水煎醇沉液能明显降低红细胞压积,缩短血浆再钙化时间,抑制血小板聚集,防止血栓形成。水提液对多种细菌具有抑制作用。
麝香:辛,温。归心、脾经。开窍醒神,活血通经,消肿止痛。善治闭证神昏,疮疡肿毒,咽喉肿痛,血瘀经闭,心腹暴痛,跌打损伤,风寒湿痹,难产,死胎等多种病症,为伤科要药。麝香对中枢神经系统的作用是双向的,小剂量兴奋,大剂量则抑制,增强中枢神经系统的耐缺氧能力,改善脑循环;麝香具有明显的强心作用,能兴奋心脏,增加心脏收缩,增强心肌功能;同时本品有一定的抗炎作用,其抗炎作用与氢化可的松相似。
本发明的有益效果是:
本发明结合中医基础理论和现代医学成果,经过反复筛选和多年临床验证,所制得的膏药配方合理,具有活血化瘀、行气止痛、消肿生肌、续筋接骨之功效,对于各种骨折等跌打损伤疗效显著,见效快,7天换药一次,治愈时间短,一般粉碎性骨折,多在1-2个月痊愈。软组织伤,7天左右痊愈。安全可靠,无毒副作用,且成本低廉,使用方便,制作方法简单。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1:
一种治疗骨折伤的膏药,其制备原料包括中药材和药学上可接受的载体,以重量份计:
中药材包括:三七40份、续断20份、补骨脂20、土鳖虫5份、五加皮10份、生杜仲10份、红花5份、骨碎补20份、当归10份、川芎10份、乳香20份、没药20份、水蛭5份、伸筋草15份、自然铜15份、轻粉5份、血竭10份、麝香2份;
药学上可接受的载体包括:麻油2000份、黄丹1000份。
实施例2:
一种治疗骨折伤的膏药,其制备原料包括中药材和药学上可接受的载体,以重量份计:
中药材包括:三七48份、续断22份、补骨脂26份、土鳖虫15份、五加皮13份、生杜仲18份、红花12份、骨碎补28份、当归30份、川芎12份、乳香25份、没药25份、水蛭10份、伸筋草18份、自然铜22份、轻粉5份、血竭28份、麝香3.5份;
药学上可接受的载体包括:麻油2600份、黄丹1050份。
实施例3:
一种治疗骨折伤的膏药,其制备原料包括中药材和药学上可接受的载体,以重量份计:
中药材包括:三七45份、续断25份、补骨脂25、土鳖虫10份、五加皮15份、生杜仲15份、红花10份、骨碎补25份、当归20份、川芎15份、乳香25份、没药25份、水蛭8份、伸筋草25份、自然铜25份、轻粉8份、血竭20份、麝香3份;
药学上可接受的载体包括:麻油2500份、黄丹1100份。
实施例4:
一种治疗骨折伤的膏药,其制备原料包括中药材和药学上可接受的载体,以重量份计:
中药材包括:三七40份、续断26份、补骨脂20份、土鳖虫11份、五加皮17份、生杜仲12份、红花7份、骨碎补23份、当归18份、川芎18份、乳香28份、没药22份、水蛭8份、伸筋草23份、自然铜18份、轻粉8份、血竭15份、麝香3份;
药学上可接受的载体包括:麻油2200份、黄丹1100份。
实施例5:
一种治疗骨折伤的膏药,其制备原料包括中药材和药学上可接受的载体,以重量份计:
中药材包括:三七45份、续断20份、补骨脂20份、土鳖虫7份、五加皮10份、生杜仲20份、红花10份、骨碎补27份、当归15份、川芎15份、乳香21份、没药21份、水蛭9份、伸筋草16份、自然铜25份、轻粉8份、血竭12份、麝香4份;
药学上可接受的载体包括:麻油2500份、黄丹1200份。
实施例6:
一种治疗骨折伤的膏药,其制备原料包括中药材和药学上可接受的载体,以重量份计:
中药材包括:三七50份、续断30份、补骨脂30、土鳖虫15份、五加皮20份、生杜仲20份、红花15份、骨碎补30份、当归30份、川芎20份、乳香30份、没药30份、水蛭10份、伸筋草30份、自然铜30份、轻粉10份、血竭30份、麝香4份;
药学上可接受的载体包括:麻油3000份、黄丹1200份。
实施例7:
一种治疗骨折伤的膏药,其制备原料包括中药材和药学上可接受的载体,以重量份计:
中药材包括:三七47份、续断26份、补骨脂22份、土鳖虫9份、五加皮15份、生杜仲12份、红花12份、骨碎补26份、当归25份、川芎16份、乳香30份、没药28份、水蛭5份、伸筋草30份、自然铜22份、轻粉8份、血竭16份、麝香2份;
药学上可接受的载体包括:麻油2900份、黄丹1000份。
实施例8:
一种治疗骨折伤的膏药,其制备原料包括中药材和药学上可接受的载体,以重量份计:
中药材包括:三七43份、续断30份、补骨脂27份、土鳖虫11份、五加皮19份、生杜仲10份、红花12份、骨碎补26份、当归18份、川芎12份、乳香28份、没药24份、水蛭6份、伸筋草22份、自然铜16份、轻粉8份、血竭16份、麝香4份;
药学上可接受的载体包括:麻油2000份、黄丹1080份。
实施例9:
一种治疗骨折伤的膏药,其制备原料包括中药材和药学上可接受的载体,以重量份计:
中药材包括:三七50份、续断20份、补骨脂20份、土鳖虫5份、五加皮20份、生杜仲16份、红花10份、骨碎补28份、当归22份、川芎16份、乳香23份、没药25份、水蛭8份、伸筋草26份、自然铜30份、轻粉50份、血竭20份、麝香3份;
药学上可接受的载体包括:麻油2000份、黄丹1200份。
实施例10:
一种治疗骨折伤的膏药,其制备原料包括中药材和药学上可接受的载体,以重量份计:
中药材包括:三七45份、续断20份、补骨脂23份、土鳖虫15份、五加皮16份、生杜仲10份、红花5份、骨碎补26份、当归12份、川芎18份、乳香20份、没药30份、水蛭5份、伸筋草18份、自然铜22份、轻粉5份、血竭25份、麝香2份;
药学上可接受的载体包括:麻油2800份、黄丹1000份。
发明实施例1-10中治疗骨折伤的膏药的制备方法,包括以下具体步骤:
步骤一:原料准备
按原料配比称取中药材及药学上可接受的载体,所述中药材包括:三七、续断、补骨脂、土鳖虫、五加皮、生杜仲、红花、骨碎补、当归、川芎、乳香、没药、水蛭、伸筋草、自然铜、轻粉、血竭、麝香;所述药学上可接受的载体包括:麻油、黄丹;
步骤二:打粉
将称取的18味中药材用中药打粉机分别打成细粉,备用;
步骤三:熬药
选用砂锅,放入麻油烧热,投入备用的三七、续断、补骨脂、土鳖虫、五加皮、生杜仲、红花、骨碎补、当归、川芎、水蛭、伸筋草、自然铜细粉,武火烧开后改小火煎熬,煎熬过程中慢慢搅动,使药材均匀融合;
步骤四:加黄丹
油珠不散时下丹,下丹时火力要适当加旺,慢慢加入黄丹,并不断搅动;黄丹下完后,以旺火熬5-10分钟,转为小火,继续熬至药液成黑色;青烟将尽,白烟上冲,药香味散出,滴水成珠时,膏药成熟出锅;
步骤五:去火毒
出锅时向水中慢慢倒入膏药,并不断搅动膏药,待冷却后,换冷水浸泡24小时,以去火毒;
步骤六:制成
将去火毒后的膏药拧干水分,放入砂锅内小火化开,将备用的乳香、没药、轻粉、血竭、麝香细粉,边搅边慢慢加入膏药中,即得所述治疗骨折伤的膏药;
步骤七:保存
将经步骤六制成的治疗骨折伤的膏药取适量摊于备好的膏药布上,制成膏药贴。
制成的膏药贴应保存在低温、干燥、通风良好、干净卫生的环境中,以备久藏。
典型案例
1、陈某,男,45岁,内蒙古霍林郭勒市人,2017年不慎摔伤致右胫骨骨折,复位后予本发明膏药外敷固定治疗21天,痊愈。
2、刘某,男,20岁,内蒙古开鲁县宏盛村人,2016年不慎被重物砸致左手第二掌骨骨折,复位后予本发明膏药外敷固定治疗16天,痊愈。
3、聂某,男,40岁,内蒙古开鲁县开鲁镇人,2016年外伤致左脚拇趾骨折,复位后予本发明膏药外敷固定治疗26天,痊愈。
4、闫某,男,72岁,内蒙古开鲁县开鲁镇人,2015年不慎摔跤致右侧肩关节脱臼、锁骨骨折、肋骨骨折,复位后予本发明膏药外敷固定治疗38天,痊愈。
5、穆某,女,46岁,内蒙古科左中旗门达人,2014年扭伤致第三腰椎左侧横突骨折,予本发明膏药外敷固定治疗29天,痊愈。
6、吕某,男,44岁,内蒙古开鲁县坤都玲人,2014年外伤致六条肋骨骨折,予本发明膏药外敷固定治疗38天,痊愈。
7、郭某,男,70岁,内蒙古开鲁县建华镇人,2014年摔伤致左小腿胫腓骨骨折,复位后予本发明膏药外敷固定治疗28天,痊愈。
8、刘某,男,28岁,内蒙古开鲁县建华镇人,2014年摔伤致右上肢尺骨骨折,复位后予本发明膏药外敷固定治疗25天,痊愈。
9、萧某,男,54岁,内蒙古开鲁县开鲁镇人,2013年摔伤致左肱骨粉碎性骨折,复位后予本发明膏药外敷固定治疗27天,痊愈。
10、邢某,女,36岁,内蒙古开鲁县清河乡人,2013年外伤致左腓骨小头骨折,复位后予本发明膏药外敷固定治疗30天,痊愈。
以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的精神和范围。
Claims (6)
1.一种治疗骨折伤的膏药,其特征在于,其制备原料包括中药材和药学上可接受的载体,以重量份计,所述中药材包括:三七40-50份、续断20-30份、补骨脂20-30份、土鳖虫5-15份、五加皮10-20份、生杜仲10-20份、红花5-15份、骨碎补20-30份、当归10-30份、川芎10-20份、乳香20-30份、没药20-30份、水蛭5-10份、伸筋草15-30份、自然铜15-30份、轻粉5-10份、血竭10-30份、麝香2-4份;所述药学上可接受的载体包括:麻油2000-3000份、黄丹1000-1200份。
2.如权利要求1所述的治疗骨折伤的膏药,其特征在于,所述中药材包括:三七45份、续断25份、补骨脂25、土鳖虫10份、五加皮15份、生杜仲15份、红花10份、骨碎补25份、当归20份、川芎15份、乳香25份、没药25份、水蛭8份、伸筋草25份、自然铜25份、轻粉8份、血竭20份、麝香3份;所述药学上可接受的载体包括:麻油2500份、黄丹1100份。
3.如权利要求1所述的治疗骨折伤的膏药,其特征在于,所述中药材包括:三七48份、续断22份、补骨脂26份、土鳖虫15份、五加皮13份、生杜仲18份、红花12份、骨碎补28份、当归30份、川芎12份、乳香25份、没药25份、水蛭10份、伸筋草18份、自然铜22份、轻粉5份、血竭28份、麝香3.5份;所述药学上可接受的载体包括:麻油2600份、黄丹1050份。
4.如权利要求1所述的治疗骨折伤的膏药,其特征在于,所述中药材包括:三七40份、续断26份、补骨脂20份、土鳖虫11份、五加皮17份、生杜仲12份、红花7份、骨碎补23份、当归18份、川芎18份、乳香28份、没药22份、水蛭8份、伸筋草23份、自然铜18份、轻粉8份、血竭15份、麝香3份;所述药学上可接受的载体包括:麻油2200份、黄丹1100份。
5.如权利要求1所述的治疗骨折伤的膏药,其特征在于,所述中药材包括:三七45份、续断20份、补骨脂20份、土鳖虫7份、五加皮10份、生杜仲20份、红花10份、骨碎补27份、当归15份、川芎15份、乳香21份、没药21份、水蛭9份、伸筋草16份、自然铜25份、轻粉8份、血竭12份、麝香4份;所述药学上可接受的载体包括:麻油2500份、黄丹1200份。
6.一种制备如权利要求1-5中任一项所述的治疗骨折伤的膏药的方法,其特征在于,包括以下具体步骤:
步骤一:原料准备
按原料配比称取中药材及药学上可接受的载体,所述中药材包括:三七、续断、补骨脂、土鳖虫、五加皮、生杜仲、红花、骨碎补、当归、川芎、乳香、没药、水蛭、伸筋草、自然铜、轻粉、血竭、麝香;所述药学上可接受的载体包括:麻油、黄丹;
步骤二:打粉
将称取的18味中药材用中药打粉机分别打成细粉,备用;
步骤三:熬药
选用砂锅,放入麻油烧热,投入备用的三七、续断、补骨脂、土鳖虫、五加皮、生杜仲、红花、骨碎补、当归、川芎、水蛭、伸筋草、自然铜细粉,武火烧开后改小火煎熬,煎熬过程中慢慢搅动,使药材均匀融合;
步骤四:加黄丹
油珠不散时下丹,下丹时火力要适当加旺,慢慢加入黄丹,并不断搅动;黄丹下完后,以旺火熬5-10分钟,转为小火,继续熬至药液成黑色;青烟将尽,白烟上冲,药香味散出,滴水成珠时,膏药成熟出锅;
步骤五:去火毒
出锅时向水中慢慢倒入膏药,并不断搅动膏药,待冷却后,换冷水浸泡24小时,以去火毒;
步骤六:制成
将去火毒后的膏药拧干水分,放入砂锅内小火化开,将备用的乳香、没药、轻粉、血竭、麝香细粉,边搅边慢慢加入膏药中,即得所述治疗骨折伤的膏药;
步骤七:保存
将经步骤六制成的治疗骨折伤的膏药取适量摊于备好的膏药布上,制成膏药贴。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810188609.4A CN108210691A (zh) | 2018-03-07 | 2018-03-07 | 一种治疗骨折伤的膏药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810188609.4A CN108210691A (zh) | 2018-03-07 | 2018-03-07 | 一种治疗骨折伤的膏药及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108210691A true CN108210691A (zh) | 2018-06-29 |
Family
ID=62667095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810188609.4A Pending CN108210691A (zh) | 2018-03-07 | 2018-03-07 | 一种治疗骨折伤的膏药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108210691A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111317782A (zh) * | 2020-04-29 | 2020-06-23 | 泰安王氏正骨医院有限公司 | 一种正骨膏药及其制备方法 |
CN109646544B (zh) * | 2019-03-05 | 2021-08-13 | 张钦明 | 一种跌打损伤药及其制备方法 |
CN113244348A (zh) * | 2021-07-01 | 2021-08-13 | 陈会占 | 治疗跌打损伤的膏药及其制备方法 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1363272A (zh) * | 2001-11-29 | 2002-08-14 | 刘金锁 | 中医正骨药纸固定法 |
CN1435191A (zh) * | 2002-01-29 | 2003-08-13 | 罗福田 | 用于接骨的中药及其制备方法 |
CN1669562A (zh) * | 2004-03-15 | 2005-09-21 | 北京万邦医药投资有限公司 | 筋骨康复膏及其制备方法 |
CN1840053A (zh) * | 2006-01-20 | 2006-10-04 | 唐印乔 | 一种治疗风寒湿痺、骨质增生、椎间盘突出的药物及其制备工艺 |
CN1879685A (zh) * | 2006-05-09 | 2006-12-20 | 宋振江 | 骨折中药蜡疗药物 |
CN1915343A (zh) * | 2005-08-15 | 2007-02-21 | 刘忠德 | 一种治疗骨折迟缓愈合的中成药 |
CN101007040A (zh) * | 2007-01-24 | 2007-08-01 | 郑爱召 | 治疗骨折的外用药物 |
CN101417060A (zh) * | 2008-11-14 | 2009-04-29 | 蔡长宇 | 一种治疗外伤、跌打、斑秃及烧烫伤的药膏 |
CN103027978A (zh) * | 2011-10-10 | 2013-04-10 | 雷佰理 | 一种治疗跌打损伤的药物组合物及其制备方法 |
CN104524073A (zh) * | 2014-11-15 | 2015-04-22 | 阎贵坤 | 一种治疗骨折、骨裂的接骨药物及其制备方法 |
CN107213423A (zh) * | 2017-06-07 | 2017-09-29 | 李建运 | 一种接骨膏及其制备方法 |
-
2018
- 2018-03-07 CN CN201810188609.4A patent/CN108210691A/zh active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1363272A (zh) * | 2001-11-29 | 2002-08-14 | 刘金锁 | 中医正骨药纸固定法 |
CN1435191A (zh) * | 2002-01-29 | 2003-08-13 | 罗福田 | 用于接骨的中药及其制备方法 |
CN1669562A (zh) * | 2004-03-15 | 2005-09-21 | 北京万邦医药投资有限公司 | 筋骨康复膏及其制备方法 |
CN1915343A (zh) * | 2005-08-15 | 2007-02-21 | 刘忠德 | 一种治疗骨折迟缓愈合的中成药 |
CN1840053A (zh) * | 2006-01-20 | 2006-10-04 | 唐印乔 | 一种治疗风寒湿痺、骨质增生、椎间盘突出的药物及其制备工艺 |
CN1879685A (zh) * | 2006-05-09 | 2006-12-20 | 宋振江 | 骨折中药蜡疗药物 |
CN101007040A (zh) * | 2007-01-24 | 2007-08-01 | 郑爱召 | 治疗骨折的外用药物 |
CN101417060A (zh) * | 2008-11-14 | 2009-04-29 | 蔡长宇 | 一种治疗外伤、跌打、斑秃及烧烫伤的药膏 |
CN103027978A (zh) * | 2011-10-10 | 2013-04-10 | 雷佰理 | 一种治疗跌打损伤的药物组合物及其制备方法 |
CN104524073A (zh) * | 2014-11-15 | 2015-04-22 | 阎贵坤 | 一种治疗骨折、骨裂的接骨药物及其制备方法 |
CN107213423A (zh) * | 2017-06-07 | 2017-09-29 | 李建运 | 一种接骨膏及其制备方法 |
Non-Patent Citations (5)
Title |
---|
刘有亮: "手法治疗四肢闭合性骨折43例", 《中国民间疗法》 * |
吕鹏来等: "骨折的中药疗法", 《中国乡村医生杂志》 * |
国家食品药品监督管理总局执业药师资格认证中心组织编写: "《中药学专业知识.1》", 31 January 2017, 中国医药科技出版社 * |
张建德: "《俞穴敷药疗法》", 31 December 1982, 陕西科学技术出版社 * |
韩冬冬等: "中医药治疗小儿肱骨外髁翻转移位型骨折49例", 《河南中医学院学报》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109646544B (zh) * | 2019-03-05 | 2021-08-13 | 张钦明 | 一种跌打损伤药及其制备方法 |
CN111317782A (zh) * | 2020-04-29 | 2020-06-23 | 泰安王氏正骨医院有限公司 | 一种正骨膏药及其制备方法 |
CN113244348A (zh) * | 2021-07-01 | 2021-08-13 | 陈会占 | 治疗跌打损伤的膏药及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102309644B (zh) | 一种治疗骨伤的中药组合物 | |
CN104147577B (zh) | 一种用于促进骨痂生长治疗骨折的膏药 | |
CN101766773B (zh) | 一种治疗足跟痛病的中药 | |
CN104644943A (zh) | 中药组合物、含该组合物的药灸及制备方法 | |
CN105031088A (zh) | 一种治疗风湿关节炎的泡脚粉及其制备方法 | |
CN108210691A (zh) | 一种治疗骨折伤的膏药及其制备方法 | |
CN1325110C (zh) | 跌打药酒 | |
CN106729225A (zh) | 一种活络止痛贴膏及其制备方法 | |
CN102920953B (zh) | 一种治疗术后刀口不愈合的中药组合物 | |
CN1284580C (zh) | 一种治疗股骨头坏死的胶囊 | |
CN102552610B (zh) | 一种治疗骨折的中药组合物 | |
CN102671180B (zh) | 一种治疗风湿腰痛的药物及其制备方法 | |
CN103251724B (zh) | 一种治疗骨伤的外敷膏药及其制备方法 | |
CN111358864A (zh) | 一种治疗风湿骨病的外用药物 | |
CN109999150A (zh) | 一种治疗骨折骨裂的中药组合物及其制备方法 | |
CN110538272A (zh) | 一种治疗软组织损伤关节肿痛的消肿通络散及其制备方法 | |
CN103585257A (zh) | 一种治疗骨折的中药散剂 | |
CN103961434B (zh) | 一种骨折术后用中药组合物 | |
CN111265644A (zh) | 一种活骨止痛贴膏及其制备方法 | |
CN105617214A (zh) | 一种治疗疥疮的中药组合物 | |
CN106491921A (zh) | 包含虎骨的风湿膏及其制备方法 | |
CN106421255A (zh) | 一种外用中草药组合物及其应用 | |
CN118717882A (zh) | 治疗颈肩腰腿疼痛、风湿痹症以及类风湿病的中药配方 | |
CN105055971A (zh) | 一种治疗痛风膏药 | |
CN105213865A (zh) | 一种治疗冠心病的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180629 |